| Conway Regional Interfaith Dental Clinic | |
|
830 N Creek Dr Conway AR 72032-4711 | |
| (501) 932-0559 | |
| (501) 205-1983 |
| Full Name | Conway Regional Interfaith Dental Clinic |
|---|---|
| Speciality | Dentist |
| Location | 830 N Creek Dr, Conway, Arkansas |
| Authorized Official Name and Position | William Pack (CFO) |
| Authorized Official Contact | 5014502112 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Conway Regional Interfaith Dental Clinic Po Box 9662 Conway AR 72033-9662 Ph: (501) 852-1363 | Conway Regional Interfaith Dental Clinic 830 N Creek Dr Conway AR 72032-4711 Ph: (501) 932-0559 |
| NPI Number | 1043864093 |
|---|---|
| Provider Enumeration Date | 07/29/2019 |
| Last Update Date | 11/09/2023 |
| Medicare PECOS PAC ID | 3173428414 |
|---|---|
| Medicare Enrollment ID | O20191004000080 |
News Archive
In this Wall Street Journal opinion piece, Jay Winsten, associate dean at the Harvard School of Public Health, and Trish Stroman, a principal at the Boston Consulting Group, examine "the emergence in Southeast Asia of malarial parasites resistant to artemisinin - the current gold-standard drug for treating the disease," writing it "poses grave new challenges."
Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.
Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.
Montefiore Medical Center, in partnership with Boston University School of Public Health, today announced the launch of a toolkit to help prevent and control the emergence of a dangerous and highly contagious infection in healthcare settings.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043864093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
| Provider Name | Gary L Jones |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1114447216 PECOS PAC ID: 8123359023 Enrollment ID: I20191008000273 |
News Archive
In this Wall Street Journal opinion piece, Jay Winsten, associate dean at the Harvard School of Public Health, and Trish Stroman, a principal at the Boston Consulting Group, examine "the emergence in Southeast Asia of malarial parasites resistant to artemisinin - the current gold-standard drug for treating the disease," writing it "poses grave new challenges."
Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.
Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.
Montefiore Medical Center, in partnership with Boston University School of Public Health, today announced the launch of a toolkit to help prevent and control the emergence of a dangerous and highly contagious infection in healthcare settings.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
› Verified 3 days ago
News Archive
In this Wall Street Journal opinion piece, Jay Winsten, associate dean at the Harvard School of Public Health, and Trish Stroman, a principal at the Boston Consulting Group, examine "the emergence in Southeast Asia of malarial parasites resistant to artemisinin - the current gold-standard drug for treating the disease," writing it "poses grave new challenges."
Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.
Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.
Montefiore Medical Center, in partnership with Boston University School of Public Health, today announced the launch of a toolkit to help prevent and control the emergence of a dangerous and highly contagious infection in healthcare settings.
The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.
› Verified 3 days ago
Kidz Choice Dental Pa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2415 Prince St Ste 105, Conway, AR 72034 Phone: 501-327-2030 Fax: 501-327-0242 | |
Thomas Kennedy, Dds Of Arkansas Ii, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 635 Dave Ward Drive, Ste 101, Conway, AR 72034 Phone: 501-238-9801 | |
Lenderman And Meek Dental Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 841 Donaghey Ave Ste 1, Conway, AR 72034 Phone: 501-327-3800 | |
East Oak Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1600 E Oak St, Ste B, Conway, AR 72032 Phone: 501-358-4101 Fax: 501-504-2545 | |
Richard L. Wiedower, D.d.s., P.a. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 810 Salem Rd, Conway, AR 72034 Phone: 501-327-9988 Fax: 501-327-9991 | |
Luke Adlong Dds Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2755 Prince St, Conway, AR 72034 Phone: 501-733-6525 |